Cardiola Raises Additional $4M in Series E Financing Round

Cardiola AG, a Winterthur-Switzerland-based company that develops a device for treating chronic heart failure, announced today that it has raised an additional $4m in equity financing from existing and new investors.

Together with the $2.3m raised earlier this year, the total infusion of $6.3m is part of the first tranche of a $7.9m Series E financing round.

The funds are being used to commercialize in Europe the Company’s patented m.pulse® device designed to non-surgically treat Chronic Heart Failure (CHF) in a patient’s home.



Join the discussion